IBM stock forecast: Can $242 support trigger a rebound toward $250?

IBM stock forecast: Can $242 support trigger a rebound toward $250?
IBM tests $242 support

​IBM is holding up better than the broader market after the latest sell-off, but the break below its 200-day SMA keeps the recovery fragile. A defence of $242 could support a rebound toward $250, while a deeper breakdown would expose the 50-day SMA near $236.70.

IBM price prediction
24H 0.63%
$246.55
48H 0.23%
$245.57
7D 0.56%
$246.36
1M 11.91%
$274.17
3M 7.1%
$262.39
6M -10.67%
$218.86
12M -17.08%
$203.15
Current price: $245 -2.1100 0.85%
Closed 11/06
Daily range 240.35 Arrow from to Icon 246.34
Weekly range 240.35 Arrow from to Icon 259.84
Loading...

U.S. stocks suffered a sharp selloff on November 5. Concerns over tighter regulation of AI infrastructure pushed the S&P 500 down 4.4%, while the Nasdaq fell 5.5%.

Investor attention now turns to the October U.S. jobs report, due on November 6. Economists expect payrolls to rise by 65,000 while the unemployment rate remains at 4.2%. A meaningful deviation from those forecasts could add another burst of volatility to U.S. equities.

Holding $242 support could trigger a rebound toward $250

The scenario outlined previously played out in full. IBM stock reached the $255.60–260 target zone before the broader market was hit by a wave of panic selling. The price broke below the 200-day SMA and ended the session at $247.11.

In premarket trading on November 6, the stock is testing the $244–242 support zone. IBM has shown notable relative strength compared with the broader market, so the base case remains a hold above $242 followed by a rebound toward $250.

A sustained move below $242 for at least one trading day would invalidate this scenario. In that case, the correction could extend toward the 50-day SMA near $236.70.

Relative strength offers no guarantee of a sustained rebound

IBM’s relatively limited losses during the broader selloff are a positive sign, but they do not yet confirm a durable recovery. The break below the 200-day SMA has weakened the short-term technical picture, while continued nervousness across the stock market could keep buyers cautious.

IBM’s relative resilience therefore remains constructive, but it does not rule out another round of selling.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.